Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15

Benzinga Newsdesk www.benzinga.com Positive 79.5%

Neg 0% Neu 0% Pos 79.5%

Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $13 to $15.